Barriers to and facilitators of independent non-medical prescribing in clinical practice: a mixed-methods systematic review

Journal of Physiotherapy

Volumn 63, Issue 4, 2017, Pages 221-234

  Noblet, Timothy ^a,b   Marriott, John ^a   Graham Clarke, Emma ^a   Rushton, Alison ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Barriers; Facilitators; Independent prescribing; Non medical prescribing

Indexed keywords

ADULT; CLINICAL PRACTICE; CONSULTATION; EDUCATION; FEMALE; GOVERNMENT; HUMAN; MALE; MANAGER; OCCUPATION; PERCEPTION; PHYSIOTHERAPIST; PHYSIOTHERAPY; PRESCRIPTION; PROFESSIONAL DEVELOPMENT; PUBLIC FIGURE; QUALITY CONTROL; REGISTRATION; SYSTEMATIC REVIEW;

HUMANS; PHYSICAL THERAPY MODALITIES; PRESCRIPTIONS;

EID: 85030475336     PISSN: 18369553     EISSN: 18369561     Source Type: Journal    
DOI: 10.1016/j.jphys.2017.09.001     Document Type: Article

References (83)

1. Kroezen, M., Francke, A.L., Groenewegen, P.P., van Dijk, L., Nurse prescribing of medicines in Western European and Anglo-Saxon countries: A survey on forces, conditions and jurisdictional control. Int J Nurs Stud 49 (2012), 1002–1012.
2. Chartered Society of Physiotherapy, Practice Guidance for Physiotherapist Supplementary and/or Independent Prescribers in the safe use of medicines. 2016, Chartered Society of Physiotherapy, London, UK.
3. Chartered Society of Physiotherapy, Medicines, prescribing and physiotherapy. 2016, Chartered Society of Physiotherapy, London, UK.
4. Landmark decision gives UK physios a world first in prescribing rights [press release]. 2012, Chartered Society of Physiotherapy, London, UK.
5. Australian Physiotherapy Association, The Physiotherapy Prescribing Pathway: Proposal for the endorsement of registered physiotherapists for autonomous prescribing. 2015, Australian Physiotherapy Association, Melbourne, Australia.
6. Watt, S., Sword, W., Krueger, P., Implementation of a health care policy: An analysis of barriers and facilitators to practice change. BMC Health Serv Res, 5, 2005, 53.
7. Bruhn, H., Bond, C.M., Elliott, A.M., Hannaford, P.C., Lee, A.J., McNamee, P., et al. Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open, 3, 2013, e002361.
8. Marotti, S.B., Kerridge, R.K., Grimer, M.D., A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesth Intensive Care 39 (2011), 1064–1070.
9. Hale, A.R., Coombes, I.D., Stokes, J., McDougall, D., Whitfield, K., Maycock, E., et al. Perioperative medication management: Expanding the role of the preadmission clinic pharmacist in a single centre, randomised controlled trial of collaborative prescribing. BMJ Open, 3, 2013, e003027.
10. Sutcliffe, K., Thomas, J., Stokes, G., Hinds, K., Bangpan, M., Intervention Component Analysis (ICA): a pragmatic approach for identifying the critical features of complex interventions. Syst Rev 4 (2015), 1–13.
11. Oliver, S., Dickson, K., Bangpan, M., Systematic reviews: making them policy relevant. A briefing for policy makers and systematic reviewers. 2015, EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College London, London.
12. Evans-Lacko, S.J.M., McCrone, P., Thornicroft, G., Facilitators and barriers to implementing clinical care pathways. BMC Health Serv Res, 10, 2010, 1.
13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org.
14. Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ, 349, 2015, g7647.
15. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 4 (2015), 1–29.
16. Akers, J., Aguiar-Ibáñez, R., Baba-Akbari Sari, A., Beynon, S., Booth, A., Burch, J., et al. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. 2009, Centre for Reviews and Dissemination, York, UK.
17. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151 (2009), W65–W94.
18. Creswell, J., Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. 3rd ed., 2008, Sage, London, UK.
19. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., The PRISMA Group, Preferred Reporting Items for Systematic Reviews and Meta-Analyses The PRISMA Statement. PLoS Medicine, 6, 2009, e1000097.
20. Hicks, C., Research Methods for Clinical Therapists: Applied project design and analysis. 4th ed., 1999, Churchill Livingstone, London, UK.
21. Bowling, A., Research Methods in Health: Investigating health & health sciences. 2nd ed., 2001, Open University Press, Maidenhead, UK.
22. Furlan, A.D., Pennick, V., Bombardier, C., van Tulder, M., Updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 34:18 (2009), 1929–1941.
23. Sirriyeh, R., Lawton, R., Gardner, P., Armitage, G., Reviewing studies with diverse designs: the development and evaluation of a new tool. J Eval Clin Pract 18 (2012), 746–752.
24. Fenton, L., Lauckner, H., Gilbert, R., The QATSDD critical appraisal tool: comments and critiques. J Eval Clin Pract 21 (2015), 1125–1128.
25. Thomas, J., Harden, A., Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol, 8, 2008, 45.
26. Sandelowski, M., Voils, C.I., Barroso, J., Defining and designing mixed research synthesis studies. Res Sch, 13, 2006, 29.
27. Tatar, O., A Mixed Mthods Systematic Review of the Barriers and Facilitators of Medication Regimen Adherence in Primary Care Patients with Alzheimer's Dementia and Related Disorders. 2014, Department of Family Medicine, Division of Experimental Medicine, McGill University, Montreal, Canada.
28. Ryan-Woolley, B.M., McHugh, G.A., Luker, K.A., Precribing by specialist nurses in cancer and palliative care: Results of a national survey. Palliative Medicine 21 (2007), 273–277.
29. Ryan-Woolley, B., McHugh, G., Luker, K., Exploring the views of nurse prescribing among Macmillan nurses. Br J Community Nurs 13 (2008), 171–177.
30. Stenner, K., Courtenay, M., Benefits of nurse prescribing for patients in pain: nurses’ views. J Adv Nurs 63 (2008), 27–35.
31. Stenner, K., Courtenay, M., The role of inter-professional relationships and support for nurse prescribing in acute and chronic pain. J Adv Nurs 63 (2008), 276–283.
32. Avery, G., Todd, J., Green, G., Sains, K., Non-medical prescribing: the doctor–nurse relationship revisited. Nurse Prescribing 5 (2007), 109–113.
33. Courtenay, M., Carey, N., Stenner, K., Non medical prescribing leads views on their role and the implementation of non medical prescribing from a multi-organisational perspective. BMC Health Serv Res, 11, 2011, 142.
34. Ross, J.D., Kettles, A.M., Mental health nurse independent prescribing: what are nurse prescribers’ views of the barriers to implementation?. J Psychiatr Ment Health Nurs 19 (2012), 916–932.
35. Scrafton, J., McKinnon, J., Kane, R., Exploring nurses’ experiences of prescribing in secondary care: informing future education and practice. J Clin Nurs 21 (2012), 2044–2053.
36. Bradley, E., Wain, P., Nolan, P., Putting mental health nurse prescribing into practice. Nurse Prescribing 6 (2008), 15–19.
37. Carey, N., Stenner, K., Courtenay, M., Views on implementing nurse prescribing in a specialist children's hospital. Nurse Prescribing 7 (2009), 205–210.
38. Carey, N., Stenner, K., Courtenay, M., Stakeholder views on the impact of nurse prescribing on dermatology services. J Clin Nurs 19 (2010), 498–506.
39. Courtenay, M., Carey, N., Nurse prescribing by children's nurses: views of doctors and clinical leads in one specialist children's hospital. J Clin Nurs 18 (2009), 2668–2675.
40. Hall, J., Cantrill, J., Noyce, P., Why don't trained community nurse prescribers prescribe?. J Clin Nurs 15 (2006), 403–412.
41. Maclure, K., George, J., Diack, L., Bond, C., Cunningham, S., Stewart, D., Views of the Scottish general public on non-medical prescribing. Int J Clin Pharm 35 (2013), 704–710.
42. McCann, L., Haughey, S., Parsons, C., Lloyd, F., Crealey, G., Gormley, G.J., et al. Pharmacist prescribing in Northern Ireland: a quantitative assessment. Int J Clin Pharm 33 (2011), 824–831.
43. McCann, L., Lloyd, F., Parsons, C., Gormley, G., Haughey, S., Crealey, G., et al. They come with multiple morbidities: A qualitative assessment of pharmacist prescribing. J Interprofessional Care 26 (2012), 127–133.
44. Travers, J., Professional issues for the future of nurse prescribing: a qualitative study. Nurse Prescribing 3 (2005), 164–167.
45. Bennett, J., Jones, M., Nurse prescribing in HIV: opportunities and threats. HIV Nursing 8 (2008), 12–16.
46. Stenner, K., Carey, N., Courtenay, M., Implementing nurse prescribing: a case study in diabetes. J Adv Nurs 66 (2010), 522–531.
47. Guirguis, L.M., Makowsky, M., Hughes, C., Sadowski, C., Yuksel, N., Exploring pharmacists’ adoption of prescribing in Alberta. Can Pharm J, 145, 2012, S10.
48. Glod, C.A., Manchester, A., Prescribing patterns of advanced practice nurses: contrasting psychiatric mental health CNS and NP practice. Clin Excell Nurse Pract 4 (2000), 22–29.
49. Hobson, R.J., Scott, J., Sutton, J., Pharmacists and nurses as independent prescribers: Exploring the patient's perspective. Fam Pract 27 (2010), 110–120.
50. Jones, K., Edwards, M., While, A., Nurse prescribing roles in acute care: an evaluative case study. J Adv Nurs 67 (2011), 117–126.
51. Bradley, E., Nolan, P., Impact of nurse prescribing: a qualitative study. J Adv Nurs 59 (2007), 120–128.
52. While, A.E., Biggs, K.S.M., Benefits and challenges of nurse prescribing. J Adv Nurs 45 (2004), 559–567.
53. Nolan, P., Carr, N., Doran, M., Nurse prescribing: the experience of psychiatric nurses in the United States. Nursing Standard 18:26 (2004), 33–38.
54. Kelly, A., Neale, J., Rollings, R., Barriers to extended nurse prescribing among practice nurses. Community Pract 83 (2010), 21–24.
55. Downer, F., Shepherd, C.K., District nurses prescribing as nurse independent prescribers. Br J Community Nurs 15 (2010), 348–352.
56. Hales, A., Perspectives on prescribing: pioneers’ narratives and advice. Perspect Psychiatr Care 38 (2002), 79–88.
57. Earle, E.A., Taylor, J., Peet, M., Grant, G., Nurse prescribing in specialist mental health (Part 1): the views and experiences of practising and non-practising nurse prescribers and service users. J Psychiatr Ment Health Nurs 18 (2011), 189–197.
58. Lewis-Evans, A., Jester, R., Nurse prescribers’ experiences of prescribing. J Clin Nurs 13:7 (2004), 796–805.
59. Makowsky, M.J., Guirguis, L.M., Hughes, C.A., Sadowski, C.A., Yuksel, N., Factors influencing pharmacists’ adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci, 8, 2013, 109.
60. Stenner, K.L., Courtenay, M., Carey, N., Consultations between nurse prescribers and patients with diabetes in primary care: A qualitative study of patient views. Int J Nurs Stud 48 (2011), 37–46.
61. Stenner, K., Carey, N., Courtenay, M., Nurse prescribing in dermatology: doctors’ and non-prescribing nurses’ views. J Adv Nurs 65 (2009), 851–859.
62. Cousins, R., Donnell, C., Nurse prescribing in general practice: a qualitative study of job satisfaction and work-related stress. Fam Pract 29 (2012), 223–227.
63. Hutchison, M., Lindblad, A., Guirguis, L., Cooney, D., Rodway, M., Survey of Alberta hospital pharmacists’ perspectives on additional prescribing authorization. Am J Health Syst Pharm 69:22 (2012), 1983–1992.
64. Page, D., Grant, G., Maybury, C., Introducing nurse prescribing in a memory clinic: service user and family carer experiences. Dementia 7 (2008), 139–160.
65. Mulholland, P.J., Pharmacists as non-medical prescribers: what role can they play? The experience in a neonatal intensive care unit. Eur J Hosp Pharm-Sci Pract 21 (2014), 335–338.
66. Courtenay, M., Carey, N., Nurse independent prescribing and nurse supplementary prescribing practice: national survey. J Adv Nurs 61 (2008), 291–299.
67. Farrell, C., Molassiotis, A., Beaver, K., Heaven, C., Exploring the scope of oncology specialist nurses’ practice in the UK. Eur J Oncol Nurs 15 (2011), 160–166.
68. Kaplan, L., Brown, M.A., Prescriptive authority and barriers to NP practice. Nurse Pract 29 (2004), 28–35.
69. Larsen, D., Issues affecting the growth of independent prescribing. Nursing Standard 19 (2004), 33–39.
70. Gumber, R., Khoosal, D., Gajebasia, N., Non-medical prescribing: audit, practice and views. J Psychiatr Ment Health Nurs 19 (2012), 475–481.
71. Courtenay, M., Carey, N., Stenner, K., An overview of non medical prescribing across one strategic health authority: a questionnaire survey. BMC Health Serv Res, 12, 2012, 138.
72. Latter, S., Blenkinsopp, A., Smith, A., Chapman, S., Tinelli, M., Gerard, K., et al. Evaluation of nurse and pharmacist independent prescribing. 2010, University of Southampton; Keele University.
73. Lim, R.H., Courtenay, M., Fleming, G., Roles of the non-medical prescribing leads within organisations across a Strategic Health Authority: perceived functions and factors supporting the role. Int J Pharm Pract 21 (2013), 82–91.
74. Guirguis, L.M., Makowsky, M.J., Hughes, C.A., Sadowski, C.A., Schindel, T.J., Yuksel, N., How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration. J Clin Pharm Therapeut 39 (2014), 390–398.
75. Hall, J., Cantrill, J., Noyce, P., Influences on community nurse prescribing. Nurse Prescribing 1 (2003), 127–132.
76. Hill, D.R., Conroy, S., Brown, R.C., Burt, G.A., Campbell, D., Stakeholder views on pharmacist prescribing in addiction services in NHS Lanarkshire. J Subst Use 19 (2014), 56–67.
77. Luker, K., Austin, L., Hogg, C., Ferguson, B., Smith, K., Patients’ views of nurse prescribing. Nursing Times 93:17 (1997), 51–54.
78. Shannon, E., Spence, W., The attitudes and views of GPs and physicians to prescribing by heart failure nurse specialists. Br J Card Nurs 6 (2011), 450–455.
79. Wix, S., Independent nurse prescribing in the mental health setting. Nursing Times 103:44 (2007), 30–31.
80. Young, D., Nurse prescribing: an interpretative phenomenological analysis. Prim Health Care 19 (2009), 32–36.
81. Stenner, K.L., Courtenay, M., Cannons, K., Nurse prescribing for inpatient pain in the United Kingdom: A national questionnaire survey. Int J Nurs Stud 48 (2011), 847–855.
82. National Prescribing Centre, A single competency framework for all prescribers. 2012, National Institute for Clinical Excellence, London, UK.
83. Hannes K. Critical appraisal of qualitative research. In: Noyes J, Booth A, Hannes K, Harden A, Harris J, Lewin S, et al., eds. Supplementary Guidance for Inclusion of Qualitative Research in Cochrane Systematic Reviews of Interventions. Version 1 (updated August 2011). Cochrane Collaboration Qualitative Methods Group, 2011. Available from URL http://cqrmg.cochrane.org/supplemental-handbook-guidance.